Order Article Reprints

Gavriilaki E, Dalampira D, Theodorakakou F, Liacos C-I, Kanellias N, Eleutherakis-Papaiakovou E, Terpos E, Gavriatopoulou M, Verrou E, Triantafyllou T, et al. Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls. Journal of Clinical Medicine. 2022; 11(12):3355. https://doi.org/10.3390/jcm11123355

Gavriilaki, Eleni, Dimitra Dalampira, Foteini Theodorakakou, Christine-Ivy Liacos, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Evangelos Terpos, Maria Gavriatopoulou, Evgenia Verrou, Theodora Triantafyllou, and et al. 2022. "Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls" Journal of Clinical Medicine 11, no. 12: 3355. https://doi.org/10.3390/jcm11123355

Gavriilaki, E., Dalampira, D., Theodorakakou, F., Liacos, C.-I., Kanellias, N., Eleutherakis-Papaiakovou, E., Terpos, E., Gavriatopoulou, M., Verrou, E., Triantafyllou, T., Sevastoudi, A., Koravou, E.-E., Touloumenidou, T., Varelas, C., Papalexandri, A., Sakellari, I., Dimopoulos, M. A., Kastritis, E., & Katodritou, E. (2022). Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls. Journal of Clinical Medicine, 11(12), 3355. https://doi.org/10.3390/jcm11123355